Your Organization Entered Into An Interoperability Agreement

22 Dec Your Organization Entered Into An Interoperability Agreement

(*) DECISION (EU) 2015/2240 EUROPEAN PARLEMENT AND TIP of 25 November 2015 establishing a programme of interoperability solutions and a common framework for European public administrations, businesses and citizens (ISA2 programme), as a means of modernising the public sector. DESCRIPTION: An organizational interoperability agreement is a private resource that formalizes governance rules that allow cooperation between digital public services with transparent functional value. “We are constantly working to support more processing machines at RayCare, and I am very pleased that we have now reached this agreement. Interoperability with Varian TrueBeam will significantly increase the market potential of RayCare and improve the workflow for our existing customers. The agreement should include objectives and objectives, conditions and conditions, governance and channel description. EIRA© distinguishes the following interoperability agreements: RaySearch Laboratories AB (publ) and Varian Medical Systems have entered into an interoperability agreement that allows the RayCare oncology information system® to connect to Varian TrueBeam linear advertisers. Interoperability SALIENCY: IoP Dimension: Governance IoP Concrete and binding documents that outline the specific commitments of two parties that cooperate through an “interface” to achieve interoperability. The ability to plan radiological treatments and monitor the progress of treatment is a key function in an oncology information system. As part of the announced agreement, a dedicated interface has been defined, allowing RayCare and Varian TrueBeam to communicate the data needed for an integrated workflow. This means that clinics can use RayCare to manage all clinical activities around their Varian TrueBeam accelerators. The development of the interface is already underway and the aim is to publish it before the end of 2020. Commercial availability is subject to regulatory approval in certain markets.

This information is information that RaySearch Laboratories AB (publ) is required to publish under the EU Market Abuse Regulation (The information was released for publication on 28 May 2020 at 13:00 CET via the aforementioned Contact Persons Agency. Source ISA2, EIFv2ec.europa.eu/isa2/isa2_en About RaySearch RaySearch is a medical technology company that develops innovative software solutions to improve cancer treatment. The company markets its RayStation processing system and the next-generation RayCare oncology information system worldwide. More than 2,600 clinics in more than 65 countries use RaySearch software to improve life and patient outcomes. The company was founded in 2000 and has been listed on Nasdaq Stockholm since 2003. ICAO Service Level Agreement Template A Service Level Agreement (SLA) is an example of an interoperability agreement whereby parties agree on the description of services to be provided by one or more parties of the other parties. The ALS deals with topics such as: service description, optional services, exclusions, restrictions, service levels, service credits, escalation procedures, reporting and contact points.www.icao.int/ESAF/Documents/APIRG/APIRG18/Docs/wp17_appendices_… About RayCare RayCare was designed to support the complex logistical challenges of modern oncology clinics.